European Penthrox Update
12 August 2016
European Penthrox Update.
Medical Developments International Limited (ASX: MVP) advises that the roll out and acceptance of Penthrox in the United Kingdom, Republic of Ireland and the EU is going to plan.
CEO of Medical Developments, Mr. John Sharman said: “We have just received our first order from Mundipharma for the French market and expect another order shortly for Belgium. The French order is the largest single order in our company’s history.”
For details relating to the full ASX release, please click on the following link ASX Announcement_European Penthrox Update_120816